The Company contracts with two specialty pharmacies, Orsini Pharmaceutical Services, Inc. ("Orsini") and AllCare Plus Pharmacy, Inc. ("AllCare") to distribute MACI in a manner in which the Company re…
USAspending awards from Department of Health and Human Services: $34,880,933 across 1 awards. 75A50126C00002 NON SURGICAL DEBRIDEMENT | Qwen corrected direction: Explicit government contract awards f…
tical Services, Inc. (“Orsini”) and AllCare Plus Pharmacy, Inc. (“AllCare”) to distribute MACI in a manner in which the Company retains the credit and collection risk from the end customer. The Compa…
In addition, the Company sells MACI directly to hospitals pursuant to an agreed upon purchase order and to a distributor, DMS Pharmaceutical Group, Inc. ("DMS") at a contracted rate for the treatment…
ew manufacturing facility in Burlington, Massachusetts, the ability to sustain profitability, contributions to adjusted EBITDA, the expected target surgeon audience, potential fluctuations in sales a…
Reciprocal relationship from MDWD graph: Reciprocal relationship from VCEL graph: Reciprocal relationship from MDWD graph: Reciprocal relationship from VCEL graph: ew manufacturing facility in Burlin…
Officer. G. Is This Insider Trading Policy Subject to Modification? The Company may at any time change this Insider Trading Policy or adopt such other policies or procedures which it considers approp…
Vericel Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
VCEL-DEBT
Debt stack $95.0M
90%
Market cache reports total debt of $95.0M.
VCEL-DEBT-13307
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2017-12-31.
VCEL-DEBT-13306
Warrants outstanding: 4.27
90%
xbrl warrant detail from xbrl 2020-12-31.
Vericel Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Vericel Corporation.
Vericel Corporation Ownership
Holder
Name
Confidence
Evidence
VCEL-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 282 tracked holders.